SCHEMBL5167914

SCHEMBL5167914

O=C1NC(=O)C(Cc2ccc(-c3ccc(C(=O)O)cc3)o2)S1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
INSR P06213 1/20 0.42
IGF1R P08069 1/20 0.42
KDM4E B2RXH2 7/20 0.42
TDP1 Q9NUW8 4/20 0.42
CDK2 P24941 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
MAPT P10636 6/20 0.41
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
TSHR P16473 2/20 0.40
HTT P42858 2/20 0.40
PPARG P37231 4/20 0.40
ALDH1A1 P00352 6/20 0.39
PKM P14618 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39
SAE1 Q9UBE0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5169080 0.87 PPARG (0.49) KDM4ETDP1MAPTTSHRHTT
SCHEMBL5167894 0.87 PIK3CG (0.50) KDM4ETDP1MAPTGSK3AGSK3B
SCHEMBL15356751 0.85 FFAR1 (0.49) IGF1RKDM4EMAPTTSHRHTT
SCHEMBL5447795 0.84 MAPT (0.60) KDM4ETDP1MAPTHTTPPARG
SCHEMBL14518737 0.81 KDM4E (0.40) INSRIGF1RKDM4ETDP1CDK2
SCHEMBL5167121 0.78 KCNH2 (0.49) KDM4ETDP1MAPTGSK3AGSK3B
SCHEMBL210722 0.77 MAPT (0.67) KDM4ETDP1MAPTTSHRHTT
SCHEMBL5167984 0.76 FFAR1 (0.48) KDM4EMAPTPPARGALDH1A1MAOA
SCHEMBL5451781 0.74 HPGD (0.54) KDM4EMAPTPPARGALDH1A1POLB
SCHEMBL5168227 0.74 RXRA (0.49) KDM4EPPARGALDH1A1GAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1774958-A1 Use of phenylfurylmethylthiazolidine-2,4-dione or phenylthienylmethylthiazolidine-2,4-dione compounds for promoting and/or inducing and/or stimulating the pigmentation of keratinous substances and/or limiting their depigmentation and/or their whitening L'Oréal (FR) 2007-04-18 EP claimed
EP-1775294-A1 Phenyl-furyl-methyl-thiazolidine-2,4-dione or phenyl-thienyl-methyl-thiazolidine-2,4-dione compounds; use for stimulating or inducing keratin fibre growth and/or slowing down their loss; compostions thereof L'Oréal (FR) 2007-04-18 EP claimed
US-20070078175-A1 Administration of novel phenylfurylmethylthiazolidine-2,4-dione and phenylthienylmethylthiazolidine-2,4-dione compounds for stimulating or inducing the growth of keratinous fibers and/or slowing loss thereof L'OREAL (FR) 2007-04-05 US claimed
US-20070077215-A1 Administration of phenylfurymethylthiazolidine-2,4-dione or phenylthienymethylthiazolidine-2,4-dione compounds for promoting and/or inducing and/or stimulating the pigmentation of keratinous substances and/or limiting their depigmentation and/or their whitening L'OREAL (FR) 2007-04-05 US claimed
EP-1774958-A1 Use of phenylfurylmethylthiazolidine-2,4-dione or phenylthienylmethylthiazolidine-2,4-dione compounds for promoting and/or inducing and/or stimulating the pigmentation of keratinous substances and/or limiting their depigmentation and/or their whitening L'Oréal (FR) 2007-04-18 EP disclosed
EP-1774958-A1 Use of phenylfurylmethylthiazolidine-2,4-dione or phenylthienylmethylthiazolidine-2,4-dione compounds for promoting and/or inducing and/or stimulating the pigmentation of keratinous substances and/or limiting their depigmentation and/or their whitening L'Oréal (FR) 2007-04-18 EP disclosed
EP-1775294-A1 Phenyl-furyl-methyl-thiazolidine-2,4-dione or phenyl-thienyl-methyl-thiazolidine-2,4-dione compounds; use for stimulating or inducing keratin fibre growth and/or slowing down their loss; compostions thereof L'Oréal (FR) 2007-04-18 EP disclosed
EP-1775294-A1 Phenyl-furyl-methyl-thiazolidine-2,4-dione or phenyl-thienyl-methyl-thiazolidine-2,4-dione compounds; use for stimulating or inducing keratin fibre growth and/or slowing down their loss; compostions thereof L'Oréal (FR) 2007-04-18 EP disclosed
US-20070078175-A1 Administration of novel phenylfurylmethylthiazolidine-2,4-dione and phenylthienylmethylthiazolidine-2,4-dione compounds for stimulating or inducing the growth of keratinous fibers and/or slowing loss thereof L'OREAL (FR) 2007-04-05 US disclosed
US-20070078175-A1 Administration of novel phenylfurylmethylthiazolidine-2,4-dione and phenylthienylmethylthiazolidine-2,4-dione compounds for stimulating or inducing the growth of keratinous fibers and/or slowing loss thereof L'OREAL (FR) 2007-04-05 US disclosed
US-20070078175-A1 Administration of novel phenylfurylmethylthiazolidine-2,4-dione and phenylthienylmethylthiazolidine-2,4-dione compounds for stimulating or inducing the growth of keratinous fibers and/or slowing loss thereof L'OREAL (FR) 2007-04-05 US disclosed
US-20070077215-A1 Administration of phenylfurymethylthiazolidine-2,4-dione or phenylthienymethylthiazolidine-2,4-dione compounds for promoting and/or inducing and/or stimulating the pigmentation of keratinous substances and/or limiting their depigmentation and/or their whitening L'OREAL (FR) 2007-04-05 US disclosed
US-20070077215-A1 Administration of phenylfurymethylthiazolidine-2,4-dione or phenylthienymethylthiazolidine-2,4-dione compounds for promoting and/or inducing and/or stimulating the pigmentation of keratinous substances and/or limiting their depigmentation and/or their whitening L'OREAL (FR) 2007-04-05 US disclosed
US-20070077215-A1 Administration of phenylfurymethylthiazolidine-2,4-dione or phenylthienymethylthiazolidine-2,4-dione compounds for promoting and/or inducing and/or stimulating the pigmentation of keratinous substances and/or limiting their depigmentation and/or their whitening L'OREAL (FR) 2007-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070077215-A1 Administration of phenylfurymethylthiazolidine-2,4-dione or phenylthienymethylthiazolidine-2,4-dione compounds for promoting and/or inducing and/or stimulating the pigmentation of keratinous substances and/or limiting their depigmentation and/or their whitening TYR, KRT18, MITF INSR 4704/4885IGF1R 3451/4885KDM4E 293/4885
US-20070078175-A1 Administration of novel phenylfurylmethylthiazolidine-2,4-dione and phenylthienylmethylthiazolidine-2,4-dione compounds for stimulating or inducing the growth of keratinous fibers and/or slowing loss thereof KRT18, NGF, FGF1 INSR 4480/4885IGF1R 1426/4885KDM4E 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.